Deferred Tax Assets, Net of Valuation Allowance in USD of Protara Therapeutics, Inc. from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Protara Therapeutics, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2013 to Q4 2024.
  • Protara Therapeutics, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2024 was $1.76K.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.76K -$1.57M Dec 31, 2024 10-K 2025-03-05
Q4 2023 $1.57M* +$93K Dec 31, 2023 10-K 2025-03-05
Q4 2022 $1.48M* -$71K Dec 31, 2022 10-K 2024-03-13
Q4 2021 $1.55M* +$1.23M Dec 31, 2021 10-K 2023-03-08
Q4 2020 $322K +$320K +16000% Dec 31, 2020 10-K 2022-03-09
Q4 2019 $2K Dec 31, 2019 10-K 2021-03-11
Q4 2017 $0 $0 Dec 31, 2017 10-K 2018-03-14
Q4 2016 $0 $0 Dec 31, 2016 10-K 2018-03-14
Q4 2015 $0 $0 Dec 31, 2015 10-K 2018-03-14
Q4 2014 $0 $0 Dec 31, 2014 10-K 2017-03-16
Q4 2013 $0 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.